Page last updated: 2024-08-25

1,2,3,6-tetragalloylglucose and Alzheimer Disease

1,2,3,6-tetragalloylglucose has been researched along with Alzheimer Disease in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Anand, P; Kumar, N; Kumar, V; Ranjan Dwivedi, A1

Reviews

1 review(s) available for 1,2,3,6-tetragalloylglucose and Alzheimer Disease

ArticleYear
Advancements in the development of multi-target directed ligands for the treatment of Alzheimer's disease.
    Bioorganic & medicinal chemistry, 2022, 05-01, Volume: 61

    Topics: Alzheimer Disease; Amyloid beta-Peptides; Cholinesterase Inhibitors; Humans; Ligands; tau Proteins

2022